CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition

BACKGROUND: Adjuvant chemotherapy offered to treat colon cancer is based on the TNM staging system, which often fails due to molecular heterogeneity and undefined molecular mechanisms independent of TNM. Therefore, identification of markers to better predict therapeutic option and outcome is needed....

Descripción completa

Detalles Bibliográficos
Autores principales: Kapur, Neeraj, Mir, Hina, Clark III, Clarence E, Krishnamurti, Uma, Beech, Derrick J, Lillard, James W, Singh, Shailesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984452/
https://www.ncbi.nlm.nih.gov/pubmed/27149649
http://dx.doi.org/10.1038/bjc.2016.113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984452/
https://www.ncbi.nlm.nih.gov/pubmed/27149649
http://dx.doi.org/10.1038/bjc.2016.113

Ejemplares similares